Log in
Enquire now
BRILINTA

BRILINTA

(ticagrelor) Tablets

OverviewStructured DataIssuesContributors

Contents

brilinta.com
Is a
Product
Product

Product attributes

Industry
Pharmaceutical and Medicine Manufacturing
Pharmaceutical and Medicine Manufacturing
Product Parent Company
AstraZeneca
AstraZeneca

BRILINTA is a prescription medicine for adults used to:

  • decrease your risk of death, heart attack, and stroke in people with a blockage of blood flow to the heart (acute coronary syndrome or ACS) or a history of a heart attack. BRILINTA can also decrease your risk of blood clots in your stent in people who have received stents for the treatment of ACS.
  • decrease your risk of a first heart attack or stroke in people who have a condition where the blood flow to the heart is decreased (coronary artery disease or CAD) who are at high risk for having a heart attack or stroke.
  • decrease your risk of stroke in people who are having a stroke (acute ischemic stroke) or temporary stroke-like symptoms, known as a mini-stroke or transient ischemic attack.

Please read Important Product Information on adjacent page and discuss with your doctor.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like BRILINTA

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.